In addition, roflumilast therapy rescued the reduced Akt phosphorylation to insulin stimulation in different tissues (liver, fat and skeletal muscle), which revealed severe insulin resistance (Fig. S2A–C). This evidence concerns the gene AKT1 and Insulin resistance.